💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

WuXi Biologics (2269)

Hong Kong
Currency in HKD
Disclaimer
12.32
+0.20(+1.65%)
Delayed Data
2269 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
12.0612.48
52 wk Range
10.1452.45
Bid/Ask
12.30 / 12.32
Prev. Close
12.12
Open
12.16
Day's Range
12.06-12.48
52 wk Range
10.14-52.45
Volume
29,908,142
Average Volume (3m)
42,720,280
1-Year Change
-71.11%
Fair Value
Unlock
Fair Value Upside
Unlock
2269 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
17.55
Upside
+42.45%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple
Show more

WuXi Biologics Company Profile

WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufacturing organization platforms, including WuXiBody, SDArBodY, T cell engager, Single B Cell Cloning Technology, WuXia, WuXiUP, WuXiUI, and WuXiHigh. It also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, production and sales of medicals, and biologics clinical and manufacturing services; production and sale of medicals; vaccine contract development and manufacturing organization (CDMO) and related business; and engages in investment and material supplier activities. The company has a research service agreement with BioNTech SE to discover and investigate monoclonal antibodies for developing next-generation therapeutic product candidates. The company was incorporated in 2014 and is headquartered in Wuxi, China.

Employees
12740
Market
Hong Kong

Compare 2269 to Peers and Sector

Metrics to compare
2269
Peers
Sector
Relationship
P/E Ratio
17.2x13.6x−0.6x
PEG Ratio
−0.470.020.00
Price/Book
1.1x2.1x2.6x
Price / LTM Sales
2.7x4.3x3.1x
Upside (Analyst Target)
44.6%18.2%55.0%
Fair Value Upside
Unlock0.9%6.8%Unlock

People Also Watch

5.04
1093
+7.46%
14.42
2331
+4.19%
114.70
0669
+2.96%
86.60
2015
+4.15%
15.86
2899
+2.45%

FAQ

What Is the WuXi Biologics (2269) Stock Price Today?

The WuXi Biologics stock price today is 12.32

What Stock Exchange Does WuXi Biologics Trade On?

WuXi Biologics is listed and trades on the Hong Kong stock exchange.

What Is the Stock Symbol for WuXi Biologics?

The stock symbol for WuXi Biologics is "2269."

What Is the WuXi Biologics Market Cap?

As of today, WuXi Biologics market cap is 49.86B.

What is WuXi Biologics Earnings Per Share?

The WuXi Biologics EPS is 0.636.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.